Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 259

    Sangam Health Cares former promoter settles case with SEBI, pays Rs 48 Lakh

    Sangam Health Care's former promoter settles case with SEBI, pays Rs 48 Lakh

    Ruby Khatun Khatun4 July 2018 10:00 AM IST
    New Delhi: Markets regulator SEBI has settled a case related to alleged disclosure lapses by an erstwhile promoter of pharmaceutical firm Sangam...
    Roche highly encouraged by Tecentriq results in breast cancer

    Roche highly encouraged by Tecentriq results in breast cancer

    Ruby Khatun Khatun4 July 2018 9:45 AM IST
    ZURICH: Swiss drugmaker Roche said that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of...
    Sanofi beefs up diabetes pipeline to retrieve success

    Sanofi beefs up diabetes pipeline to retrieve success

    Ruby Khatun Khatun4 July 2018 9:30 AM IST
    PARIS: Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and...
    Natco launches Hepatitis C drug in India at Rs 17,500

    Natco launches Hepatitis C drug in India at Rs 17,500

    Ruby Khatun Khatun3 July 2018 10:30 AM IST
    Hyderabad: Natco Pharma said it has launched a fixed-dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the...
    Boiron launches pre-medicated homeopathic medicines in India

    Boiron launches pre-medicated homeopathic medicines in India

    Ruby Khatun Khatun3 July 2018 10:15 AM IST
    New Delhi: Boiron India, subsidiary of Boiron France, has launched pre-medicated standardized homeopathic medicines for the first time in the...
    Ferring launches work on facility in Hyderabads Genome Valley

    Ferring launches work on facility in Hyderabad's Genome Valley

    Ruby Khatun Khatun3 July 2018 10:00 AM IST
    Hyderabad: Ferring Pharmaceuticals, a pharma major from Europe, laid the foundation stone for their state-of-the-art R&D laboratory and...
    Novartis hands investors Alcon spin-off, 5 billion dollar share buyback

    Novartis hands investors Alcon spin-off, 5 billion dollar share buyback

    Ruby Khatun Khatun3 July 2018 9:45 AM IST
    ZURICH: Novartis plans to spin off its Alcon eye care business to shareholders and buy back up to $5 billion in stock as Chief Executive Vas...
    AstraZeneca wins speedy approvals for cancer drugs in Japan

    AstraZeneca wins speedy approvals for cancer drugs in Japan

    Ruby Khatun Khatun3 July 2018 9:30 AM IST
    LONDON: AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first...
    Dr Reddys recalls 2.36 lakh bottles of cholesterol lowering tablets from US

    Dr Reddy's recalls 2.36 lakh bottles of cholesterol lowering tablets from US

    Ruby Khatun Khatun2 July 2018 11:37 AM IST
    New Delhi: Dr Reddy's Laboratories is recalling from the US over 2.36 lakh bottles of Atorvastatin Calcium tablets used for lowering cholesterol, as...
    Zydus Cadila gets USFDA nod for blood pressure drug

    Zydus Cadila gets USFDA nod for blood pressure drug

    Ruby Khatun Khatun2 July 2018 10:30 AM IST
    New Delhi: Zydus Cadila said it has received USFDA approval to market Triamterene and Hydrochlorothiazide tablets, indicated to treat high blood...
    Rival Novartis, Gilead CAR-T therapies win European panel recommendation

    Rival Novartis, Gilead CAR-T therapies win European panel recommendation

    Ruby Khatun Khatun2 July 2018 10:00 AM IST
    ZURICH: Rival cancer cell therapies from Swiss drugmaker Novartis and U.S.-based Gilead Sciences won a key recommendation from a European Medicines...
    AbbVie, AndroGel partner owe 448 million dollar in antitrust case: US judge

    AbbVie, AndroGel partner owe 448 million dollar in antitrust case: US judge

    Ruby Khatun Khatun2 July 2018 9:45 AM IST
    A U.S. judge found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok